Satoru Kyo

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Topics

Genetic Diversity

Endometrial Cancer

Estrogen Receptor

Top Venues

Current issues in molecular biology

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Hitomi Yamashita, Kentaro Nakayama, Kosuke Kanno, Tomoka Ishibashi, Masako Ishikawa, Kouji Iida, Sultana Razia, Tohru Kiyono, Satoru Kyo
Evaluation of ARID1A as a Potential Biomarker for Predicting Response to Immune Checkpoint Inhibitors in Patients with Endometrial Cancer. Cancers 16 (11) (2024)
Kosuke Kanno, Kentaro Nakayama, Sultana Razia, Sohel Hasibul Islam, Zahan Umme Farzana, Shahataj Begum Sonia, Hitomi Yamashita, Masako Ishikawa, Tomoka Ishibashi, Kayo Imamura, Tohru Kiyono, Satoru Kyo
Association between KRAS and PIK3CA Mutations and Progesterone Resistance in Endometriotic Epithelial Cell Line. Current issues in molecular biology 46 (4) (2024)
Kosuke Kanno, Kentaro Nakayama, Sultana Razia, Sohel Hasibul Islam, Zahan Umme Farzana, Shahataj Begum Sonia, Hitomi Yamashita, Masako Ishikawa, Tomoka Ishibashi, Kayo Imamura, Tohru Kiyono, Satoru Kyo
Association between KRAS and PIK3CA Mutations and Progesterone Resistance in Endometriotic Epithelial Cell Line. Current issues in molecular biology 46 (4) (2024)
Kosuke Kanno, Kentaro Nakayama, Sultana Razia, Sohel Hasibul Islam, Zahan Umme Farzana, Shahataj Begum Sonia, Hitomi Yamashita, Masako Ishikawa, Tomoka Ishibashi, Kayo Imamura, Tohru Kiyono, Satoru Kyo
Association between KRAS and PIK3CA Mutations and Progesterone Resistance in Endometriotic Epithelial Cell Line. Current issues in molecular biology 46 (4) (2024)
Hitomi Yamashita, Kentaro Nakayama, Kosuke Kanno, Tomoka Ishibashi, Masako Ishikawa, Kouji Iida, Sultana Razia, Tohru Kiyono, Satoru Kyo
Evaluation of ARID1A as a Potential Biomarker for Predicting Response to Immune Checkpoint Inhibitors in Patients with Endometrial Cancer. Cancers 16 (11) (2024)
Sultana Razia, Kentaro Nakayama, Hitomi Yamashita, Tomoka Ishibashi, Masako Ishikawa, Kosuke Kanno, Seiya Sato, Satoru Kyo
Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study. Current oncology (Toronto, Ont.) 30 (4) (2023)
Seiya Sato, Kentaro Nakayama, Kosuke Kanno, Razia Sultana, Masako Ishikawa, Tomoka Ishibashi, Hitomi Yamashita, Satoru Kyo
Frequent PIK3CA mutation in normal endometrial gland drives spheroid formation and may be involved in stem cell propagation. Cancer science (2023)
Seiya Sato, Kentaro Nakayama, Kosuke Kanno, Razia Sultana, Masako Ishikawa, Tomoka Ishibashi, Hitomi Yamashita, Satoru Kyo
Frequent PIK3CA mutation in normal endometrial gland drives spheroid formation and may be involved in stem cell propagation. Cancer science (2023)
Kiyoka Sawada, Kentaro Nakayama, Sultana Razia, Hitomi Yamashita, Tomoka Ishibashi, Masako Ishikawa, Kosuke Kanno, Seiya Sato, Satoru Nakayama, Yoshiro Otsuki, Satoru Kyo
Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status. Healthcare (Basel, Switzerland) 11 (8) (2023)
Sultana Razia, Kentaro Nakayama, Hitomi Yamashita, Tomoka Ishibashi, Masako Ishikawa, Kosuke Kanno, Seiya Sato, Satoru Kyo
Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study. Current oncology (Toronto, Ont.) 30 (4) (2023)
Masako Ishikawa, Kentaro Nakayama, Sultana Razia, Hitomi Yamashita, Tomoka Ishibashi, Hikaru Haraga, Kosuke Kanno, Noriyoshi Ishikawa, Satoru Kyo
The Case of an Endometrial Cancer Patient with Breast Cancer Who Has Achieved Long-Term Survival via Letrozole Monotherapy. Current issues in molecular biology 45 (4) (2023)
Hitomi Yamashita, Kentaro Nakayama, Kosuke Kanno, Tomoka Ishibashi, Masako Ishikawa, Seiya Sato, Koji Iida, Sultana Razia, Satoru Kyo
Identifying the Carcinogenic Mechanism of Malignant Struma Ovarii Using Whole-Exome Sequencing and DNA Methylation Analysis. Current issues in molecular biology 45 (3) (2023)
Kiyoka Sawada, Kentaro Nakayama, Sultana Razia, Hitomi Yamashita, Tomoka Ishibashi, Masako Ishikawa, Kosuke Kanno, Seiya Sato, Satoru Nakayama, Yoshiro Otsuki, Satoru Kyo
Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status. Healthcare (Basel, Switzerland) 11 (8) (2023)
Masako Ishikawa, Kentaro Nakayama, Sultana Razia, Hitomi Yamashita, Tomoka Ishibashi, Hikaru Haraga, Kosuke Kanno, Noriyoshi Ishikawa, Satoru Kyo
The Case of an Endometrial Cancer Patient with Breast Cancer Who Has Achieved Long-Term Survival via Letrozole Monotherapy. Current issues in molecular biology 45 (4) (2023)
Sultana Razia, Kentaro Nakayama, Hitomi Yamashita, Tomoka Ishibashi, Masako Ishikawa, Kosuke Kanno, Seiya Sato, Satoru Kyo
Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study. Current oncology (Toronto, Ont.) 30 (4) (2023)
Takeo Matsumoto, Takuma Suzuki, Mitsuhiro Nakamura, Megumi Yamamoto, Takashi Iizuka, Masanori Ono, Kyosuke Kagami, Haruki Kasama, Tatsuhito Kanda, Yuya Sakai, Junpei Iwadare, Ayumi Matsuoka, Kayo Kayahashi, Kousho Wakae, Masamichi Muramatsu, Satoru Kyo, Yasuhiko Yamamoto, Yasunari Mizumoto, Takiko Daikoku, Hiroshi Fujiwara
Androgen promotes squamous differentiation of atypical cells in cervical intraepithelial neoplasia via an ELF3-dependent pathway. Cancer medicine (2023)
Hitomi Yamashita, Kentaro Nakayama, Kosuke Kanno, Tomoka Ishibashi, Masako Ishikawa, Seiya Sato, Koji Iida, Sultana Razia, Satoru Kyo
Identifying the Carcinogenic Mechanism of Malignant Struma Ovarii Using Whole-Exome Sequencing and DNA Methylation Analysis. Current issues in molecular biology 45 (3) (2023)
Hitomi Yamashita, Kentaro Nakayama, Kosuke Kanno, Tomoka Ishibashi, Masako Ishikawa, Seiya Sato, Koji Iida, Sultana Razia, Satoru Kyo
Identifying the Carcinogenic Mechanism of Malignant Struma Ovarii Using Whole-Exome Sequencing and DNA Methylation Analysis. Current issues in molecular biology 45 (3) (2023)
Kamrunnahar Shanta, Kentaro Nakayama, Mohammad Mahmud Hossain, Sultana Razia, Tomoka Ishibashi, Masako Ishikawa, Hitomi Yamashita, Kosuke Kanno, Seiya Sato, Satoru Nakayama, Yoshiro Otsuki, Satoru Kyo
Promising Therapeutic Impact of a Selective Estrogen Receptor Downregulator, Fulvestrant, as Demonstrated In Vitro upon Low-Grade Serous Ovarian Carcinoma Cell Lines. Current oncology (Toronto, Ont.) 29 (6) (2022)
Naomi Nakayama, Kentaro Nakayama, Tomoka Ishibashi, Satoru Katayama, Satoru Kyo
Effect of Muscle Loss but Not Fat Loss during Primary Debulking Surgery and Chemotherapy on Prognosis of Patients with Ovarian Cancer. Journal of clinical medicine 11 (11) (2022)
Takeo Matsumoto, Takashi Iizuka, Mitsuhiro Nakamura, Takuma Suzuki, Megumi Yamamoto, Masanori Ono, Kyosuke Kagami, Haruki Kasama, Kousho Wakae, Masamichi Muramatsu, Shin-Ichi Horike, Satoru Kyo, Yasuhiko Yamamoto, Yasunari Mizumoto, Takiko Daikoku, Hiroshi Fujiwara
FOXP4 inhibits squamous differentiation of atypical cells in cervical intraepithelial neoplasia via an ELF3-dependent pathway. Cancer science 113 (10) (2022)
Satoru Kyo, Kosuke Kanno, Masahiro Takakura, Hitomi Yamashita, Masako Ishikawa, Tomoka Ishibashi, Seiya Sato, Kentaro Nakayama
Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome Resistance. Cancers 14 (10) (2022)
Hideki Tokunaga, Mikio Mikami, Satoru Nagase, Yoichi Kobayashi, Tsutomu Tabata, Masanori Kaneuchi, Toyomi Satoh, Yasuyuki Hirashima, Noriomi Matsumura, Yoshihito Yokoyama, Kei Kawana, Satoru Kyo, Daisuke Aoki, Hidetaka Katabuchi
The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. Journal of gynecologic oncology 32 (2) (2021)
Satoru Kyo, Seiya Sato, Kentaro Nakayama
Cancer-associated mutations in normal human endometrium: Surprise or expected? Cancer science 111 (10) (2020)
Satoru Kyo, Noriyoshi Ishikawa, Kohei Nakamura, Kentaro Nakayama
The fallopian tube as origin of ovarian cancer: Change of diagnostic and preventive strategies. Cancer medicine 9 (2) (2019)